Evidence Lead, AI Access Initiative (EAII Advisors)

About The AI Access Initiative (2AI) We're at an inflection point in artificial intelligence – presenting both tremendous potential opportunity and risk for people in developing countries. AI capabilities are improving on a timescale measured in months, while development systems often move on timescales measured in decades. Much of the technology needed for positive impact exists today, but few organizations exist to bridge research, deployment, and scaled implementation: we must act now to ensure AI's benefits reach people in poverty in LMICs. Incubated at Evidence Action, we're scaling The AI Access Initiative, an organization focused on scaling AI-enabled 'big bets' to benefit tens or hundreds of millions of people in poverty in low- and middle-income countries (LMICs). We operate at the intersection of global development actors, top AI labs, and leading researchers to drive meaningful access to AI's benefits for the 3.5 billion people living in poverty globally. We create "public good," open-sourced playbooks, toolkits, and insights that define how to design and launch tractable and impactful AI-enabled programs. Given the scale of opportunity, we expect our portfolio to expand substantially, but to start, we're scaling two programs focused on AI in Agriculture and AI in Health. Agriculture: We have an ambitious goal to reach 100M+ farmers with AI-enabled weather forecasts, expand forecast R&D to generate novel forecasts, and build public and private sector (WhatsApp, telcos) delivery channels to deliver new, LLM-generated voice and image content that maximizes behavior change. Health: Here, our initial goal is to scale AI-enabled clinical decision support to 20M+ people via telemedicine platforms, dramatically improving diagnosis and health outcomes at a national level. We are also planning to explore and test novel interventions for low-resource settings, including direct-to-consumer (DTC) health interventions. We are led by former Evidence Action CEO Kanika Bahl, a founding member of Anthropic's Long-Term Benefit Trust, and advised by Nobel Laureate Michael Kremer; Dario Amodei, CEO of Anthropic; and Kent Walker, President, Global Affairs for Alphabet and Google. This work builds on Evidence Action's track record reaching 530M+ people with cost-effective, evidence-based programs across 9 countries in Africa and Asia, with a focus on last-mile delivery. About 2AI India and EAII Advisors EAII Advisors, Evidence Action's technical partner in India, supports state governments in delivering evidence-based public health programs. Operating across 10 states, EAII Advisors provides technical assistance to ministries of health, education, water, and women and child development, reducing health burdens in impoverished communities and improving the long-term wellbeing of children and families. 2AI India is being incubated as a project within EAII Advisors, with plans to spin off into an independent entity at the end of this year. We are…